The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HLA associations with immunotherapy related endocrine toxicity.
 
Zoe Quandt
Consulting or Advisory Role - Novartis
 
Christian Thorball
No Relationships to Disclose
 
Pooja Middha
No Relationships to Disclose
 
Douglas Buckner Johnson
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Mosaic ImmunoEngineering; Novartis; Pfizer; Targovax
Research Funding - Bristol-Myers Squibb; Incyte
Patents, Royalties, Other Intellectual Property - Abatacept for the use of immune related adverse events.; Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy
 
Cosmin A Bejan
No Relationships to Disclose
 
Lydia Yao
No Relationships to Disclose
 
Yaomin Xu
Research Funding - Incyte
 
Flavia Hodel
No Relationships to Disclose
 
Athina Stravodimou
No Relationships to Disclose
 
Esther Shearer-Kang
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Geoffrey Liu
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Jazz Pharmaceuticals; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Pfizer; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Melinda C Aldrich
Consulting or Advisory Role - Guardant Health
Research Funding - Genentech
 
Adam Jacob Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Elad Ziv
No Relationships to Disclose
 
Elizabeth J Phillips
Honoraria - AstraZeneca; BioCryst; Janssen; Novavax; Ramboll Esperion; Regeneron; Verve Medical
Consulting or Advisory Role - AstraZeneca; BioCryst; Janssen; Novavax; Ramboll Esperion; Regeneron; UpToDate; Verve
 
Jacques Fellay
Research Funding - Roche (Inst)
 
Ewa A Bergmann
Employment - Roche
Stock and Other Ownership Interests - Agenus (I); Roche
 
G Scott Chandler
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent pending as co-inventor of novel biomarker work performed as Roche employee
Travel, Accommodations, Expenses - Roche/Genentech
 
Justin M Balko
Stock and Other Ownership Interests - Beam Therapeutics; BioNano Genomics; crispr therapeutics
Consulting or Advisory Role - AstraZeneca; Lilly; Malinkrodt; Pfizer
Research Funding - Genentech/Roche; Incyte
Patents, Royalties, Other Intellectual Property - FCRL6 as an immunotherapy target; Patent on use of HLA-DR/MHC expression to predict response to immunotherapies
Other Relationship - NanoString Technologies
 
Ashis Saha
Employment - Genentech
Stock and Other Ownership Interests - Genentech